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Rift Valley fever virus (RVFV) (Phlebovirus, Bunyaviridae) possesses a genome composed of three negative-stranded RNA molecules. Each
segment contains 3′ and 5′ noncoding regions with terminal complementary sequences forming a panhandle structure. We showed that
transcription–replication of the L, M and S segments is regulated, and we established a minigenome rescue system expressing a CAT reporter to
investigate the role of the noncoding regions in this process. The L, M and S segment-based minigenomes were shown to drive bona fide
transcription and replication and to express variable levels of CAT reporter, indicating differential promoter activities within the noncoding
sequences. In addition, we found a good correlation between the relative promoter strength and the abundance of viral RNA species in RVFV-
infected cells. Altogether, these results show that RVFV minigenomes are powerful tools to study transcription and replication and constitute a
valuable basis to rescue infectious virus from cDNAs.
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Rift Valley fever virus (RVFV) belongs to the Phlebovirus
genus in the Bunyaviridae family (Elliott et al., 2000). It is a
pathogen of public health concern in sub-Saharan Africa and
Egypt (Meegan and Peters, 1989), which spread to Yemen and
Saudi Arabia in 2000 (Anonymous, 2000a,b). RVFV infects
humans and ruminants, causing dramatic epidemics/epizootics
and leading to major economic losses (Gerdes, 2002; Linthicum
et al., 1999; Swanepoel and Coetzer, 1994). RVFV is an
arbovirus transmitted by many species of mosquitoes. It persists
in the eggs of infected mosquitoes, explaining that the virus can
reappear after long inter-epizootic periods, especially after
excessive rainfalls during which flooding favors the hatching of
eggs and breeding of mosquitoes. The virus contains a tripartite,
negative sense RNA genome: the L and M segments code
respectively for the RNA-dependent RNA polymerase (L⁎ Corresponding author. Fax: +33 1 40 61 31 51.
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tionally cleaved, generating the mature envelope glycoproteins
GN and GC and a nonstructural protein of 14 or 78 kDa,
depending of the cleavage site (Giorgi, 1996; Schmaljohn and
Hooper, 2001). The S segment utilizes an ambisense coding
strategy and contains two open reading frames (ORF), one
expressing the nucleoprotein N in the 5′ half of the viral
antigenomic-sense molecule (cRNA) and the other encoding the
nonstructural protein NSs in the 5′ half of the genomic-sense
RNA (vRNA) (Giorgi et al., 1991). A C-rich intergenic region
(IGR) separates the two ORFs. All the steps of the viral
replication cycle take place in the cytoplasm, maturation and
budding occurring in the Golgi apparatus (Schmaljohn and
Hooper, 2001).
Like for all the negative-stranded viruses, the RVFV genome
is transcribed and replicated only when it is associated with the
nucleoprotein and the viral polymerase, forming ribonucleo-
proteins (RNPs). The viral RNPs are templates for the synthesis
of two types of RNAs, mRNAs and antigenomes (cRNAs), the
latter ones being the full-length copy of the genome (vRNA). In
contrast with genomic and antigenomic RNAs, viral mRNAs
Fig. 1. Analysis of viral RNAs in Clone 13 virions and in infected cells. [32P]-
labeled RNAs from purified Clone13 virus produced in the maintenance
medium of BSR infected cells and collected at 18 hpi (lane 1) or from Clone 13-
infected BSR cells labeled by [32P]phosphoric acid in the presence of
actinomycin D from 30 min to 7h30 (lanes 2 and 3) were extracted and
separated in a 1.6% agarose gel after denaturation with glyoxal. The gel was
dried and exposed to X-ray film. Lanes 2 and 3 represent two exposures of the
same gel. The intensities of the bands were quantified.
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(Bishop et al., 1983; Patterson and Kolakofsky, 1984) using a
mechanism similar to the situation reported for influenza virus
(Bouloy et al., 1978; Krug, 1981). Moreover, the mRNAs are
not polyadenylated at the 3′ end and are shorter than
antigenomes since the viral transcriptase terminates before the
5′ end of the template (Elliott, 1996; Schmaljohn and Hooper,
2001).
In viral infections, the level of expression of each protein is
subjected to fine regulations at transcriptional and translational
levels. For instance, in Bunyavirus infections, the nucleopro-
tein is one of the most abundant proteins in infected cells,
whereas the RNA-dependent RNA polymerase is present in
lower amounts. In LaCrosse virus infected cells, regulation was
found to occur at the transcriptional level and appears to be cell
type dependent (Rossier et al., 1988). Although this was not
the case for LaCrosse virus which contains equimolar amounts
of each L, M and S segments, different molar ratios of the
different genomic segments present in the infecting virus can
influence the relative level of protein expression, as it was
reported for the related Phlebovirus Uukuniemi (Pettersson et
al., 1977). Since such data were not available for RVFV, we
analyzed the ratio of L, M and S segments in virions and in
RVFV infected cells and clearly found that the relative
abundance of the three RNA species in infected cells is
regulated when compared to the L/M/S molar ratios in the
input virus. This study was performed in cells infected by the
NSs-deficient Clone 13 in order to eliminate NSs as a possible
factor of regulation (Ikegami et al., 2005a). It should be
recalled that Clone 13 possesses an NSs which is largely
truncated due to an internal deletion and is rapidly degraded by
the proteosome pathway (Muller et al., 1995). Among possible
factors, we investigated the role of the noncoding regions
(NCRs) in transcriptional regulation of the three RVFV RNAs.
Each RNA molecule of the tripartite genome contains 3′ and 5′
terminal NCRs composed of a terminal sequence highly
conserved within each genus, which is 8 nucleotide-long for
phleboviruses, and a more variable internal region specific for
each L, M and S segment and having various length, sequence
and degree of complementarity between the 3′ and 5′ ends.
These 3′ and 5′ sequences are complementary to each other
and form a panhandle structure specific for each segment
(Elliott, 1996). To address the role of the NCRs in transcription
regulation, we used a newly established RNA polymerase I
(pol I)-based reverse genetics system expressing a CAT
reporter and showed that it drives bona fide transcription and
replication from the L, M and S minigenomes. Altogether our
data indicate that the relative abilities of the L, M and S
genome analogs for transcription–replication were in the order
L > S > M, strongly suggesting that the NCRs of each RNA
species determine the strength of the promoter activities.
Taking into account the molar ratios of the L, M and S
segments encapsidated into infectious progeny virions and the
size of these RNA molecules, we found a good correlation
between the relative strength of the promoters and the relative
abundance of the L, M and S RNA species synthesized in
infected cells.Results
Transcription and replication of L, M and S segments are
regulated in Clone 13-infected cells
In a first step, we quantified the three viral RNA species
incorporated into RVF virions: Clone 13 grown in the
presence of [32P]phosphoric acid was purified, its RNA
molecules extracted and separated in agarose gel under
denaturing conditions (Fig. 1, lane 1). As expected, three
bands, L, M and S were observed. The intensity of each band
was measured using a PhosphoImager, and the molecular ratio
of the L/M/S species was calculated taking into account the
size of 6404, 3886 and 1141 nt for the L, M and S segments,
respectively. Several preparations of purified virions were
analyzed: on average, the molar ratio of L:M:S was 1:3.9:3.9,
showing that the M and S segments are almost in equimolar
amounts, but the L segment is less abundant. Of note, the
three RNA species include small amounts of the antigenomic
strand which were incorporated into RVFV particles (unpub-
lished data and Ikegami et al., 2005b). Such a ratio is close to
the one (1:4:2) reported for UUK virions (Pettersson et al.,
1977).
To evaluate the level of RNA synthesis of the three viral
species during viral infection, we infected BHK-21 cells with
RVFV Clone 13. Viral RNAs were labeled with [32P]
phosphoric acid from 30 min to 7.5 hpi. Actinomycin D was
added to the medium to avoid [32P] incorporation in cellular
RNAs. This incubation time was chosen because it allows
transcription and replication products to accumulate in the
cytoplasm, the virus being released in the extracellular medium
at later times. Five bands were detected in the gel: the L, M and
S RNA species and the N and NSs mRNA (Fig. 1 lanes 2 and 3,
the latter being a longer exposure of lane 2). In case of the L or
M species, genomes (vRNAs), antigenomes (cRNAs) and
mRNAs co-migrated, whereas for the S segment, the N and NSs
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The N and NSs mRNAs were estimated, respectively, to be
approximately 850 and 390 base-long from their migration
relative to size markers in denaturing gels.
To determine the level of transcription and replication
relative to each species, we quantified the intensity of L, M
and S RNAs, including vRNA, cRNA and mRNA, synthesized
in Clone 13-infected cells (Fig. 1, lane 2). The NSs
subgenomic mRNA, which is barely detectable, was not
quantified because it contributes only for a negligible
proportion. In case of the L and M segments, the unique
band represents the transcription and replication activity since
the genome, antigenome and mRNA comigrate. For the S
segment, the intensities of the full-length molecules and the N
mRNA were added. Based on the respective intensities of the
bands and their size, we calculated that the synthesis of one
molecule of L RNA was associated with 2.8 molecules of M
RNA and 12.3 molecules of S RNA, the latter ones being
composed of 6.3 of full-length S RNA, 6.0 of N mRNA and
minor amounts of subgenomic NSs mRNAs.
These results show that the level of each RNA species is
regulated in RVFV-infected cells, in a context where NSs is
inefficient. The proportion of S RNA species is higher in
infected cells compared to virions, M RNA species is lower in
infected cells than in virions, and the L species is the least
abundant. It is possible that, as described for other bunyaviruses
(Barr et al., 2003; Flick et al., 2004; Kohl et al., 2004a; Lowen
and Elliott, 2005; Lowen et al., 2005), promoters for transcrip-
tion–replication of L, M and S RNA species have different
strength and regulate the levels of RNA transcription–
replication. Thus, we established RVFV minigenome rescue
system and investigated if the relative levels of L, M and S RNA
synthesis could be due to the strength of their promoter
contained within the NCRs.
Development of RVFV L, M and S segment-based minigenomes
To address the role of the NCRs in transcription regulation,
we utilized a minigenome system in which the CAT reporter
gene ORF was cloned in the noncoding (antisense) orientation
between the 5′ (110, 271 and 38 nt) and 3′ NCRs (18, 20 and 34
nt) of the genomic L, M or S segment (vRNA). In the different
strains completely sequenced today, Clone 13, MP12 and
ZH548, the NCR sequences are fully conserved. In the case of
the S segment, the Clone13 NSs and intergenic sequences (249
nt plus 82 nt) were included to mimic the S segment more
closely and because the IGR contains a site for transcription
termination. This system will allow comparison of the control
elements located within NCRs from each genome analog
without interference of various RNA sequences and sizes, since
the templates have approximately the same size and express the
same reporter protein.
Previous reports indicated that the reconstitution of the
RVFV transcription complex requires the L and N proteins
(Ikegami et al., 2005a; Lopez et al., 1995). Therefore, the L and
N proteins were expressed in BSR cells after transfection of
pTM1-L and pTM1-N, in which the respective ORFs werecloned downstream of the T7 promoter and the IRES of EMCV
of the pTM1 plasmid, allowing protein expression via cap-
independent translation (Elroy-Stein et al., 1989). T7 RNA
polymerase was provided by co-transfection of pCMV-T7pol, a
plasmid carrying the ORF of the T7 RNA polymerase under the
CMV promoter (Radecke et al., 1995).
In the system we developed here, the minigenomes were
expressed from Pol I-based plasmids pLgCAT, pMgCAT or
pSC13gCAT, similar to those already described for other bun-
yaviruses (Flick and Pettersson, 2001, Flick et al., 2003a,b,
2004). Plasmid pRF108 containing the promoter and terminator
of the murine RNA polymerase I system served as a cloning
vector. To control transfection efficiencies and to normalize
CAT activities, pTM1-Lucfirefly, a plasmid encoding the reporter
firefly luciferase under T7 polymerase promoter and the EMCV
IRES was also constructed. Experiments were carried out to
determine the amounts and ratios of the plasmids to obtain the
optimal level of CAT activity. The conditions retained are the
following: 0.25 μg of pTM1-L and 0.5 μg of pTM1-N together
with 1 μg of pLgCAT and 2 μg of pCMV-T7pol were
transfected (data not shown). Transcription of the three RVFV
minigenomes mediated by the viral complex was then
monitored in a time course experiment by enzymatic CAT
assay using LgCAT, MgCAT or SC13gCAT as a template. Fig.
2A illustrates the data obtained after transfection of pLgCAT.
Similar data were obtained for M and S segment-based
minigenomes, and transfection efficiency was similar for each
time point as monitored by the pTM1-Lucfirefly (not shown). As
expected for these RNA molecules which possess a CAT ORF
in the noncoding orientation, no activity was found in the
absence of N and/or L (Fig. 2A, lanes 1–3). In contrast, in cells
expressing L and N, CAT activity was detected as soon as 12 h
post-transfection (lanes 5–10) indicating that L and N are the
minimal trans-acting viral factors required for transcription,
which confirms previous work (Lopez et al., 1995). CAT
activity was found to increase over time until 48 h, finally
reaching a plateau (Fig. 2A).
The L, M and S minigenomes are transcribed and replicated
like authentic viral genomes
To validate the transcription–replication system, we verified
that these artificial templates are also efficient for replication
like the authentic viral molecule. The replication activity was
demonstrated by Northern blot analyses. Minigenomes, minia-
ntigenomes and the mRNAs were analyzed using probes
annealing to the CAT sense or antisense sequences (Figs. 3A
and B). In cells transfected with each genomic plasmid and in
the absence of N protein (or L, not shown) expression, a probe
against antisense CAT detects the primary products of the
cellular pol I transcription (Fig. 3B, lanes 2, 4, 6). In the
presence of L and N proteins, genomic CAT RNAs were
detected in higher amounts (Fig. 3B, lanes 3, 5, 7),
demonstrating that the genome analog was amplified and,
therefore, that replication occurred.
We verified also that the transcriptase activity synthesizes
mRNAs which are truncated at their 3′ ends relative to the
Fig. 3. Northern blot analysis of BSR cells transfected with the set of plasmids to
reconstitute RVFV polymerase and the minigenome pLgCAT (A and B, lanes 2
and 3), pMgCAT (A and B, lanes 4 and 5) and pSC13CAT (A and B, lanes 6 and
7 and C, lanes 3 and 4) or the plasmid vector pRF108 (A and B, lanes 1).
Negative controls in which pTM1-N is lacking are shown in panels A and B,
lanes 2, 4 and 6 and in panel C, lane 3. RNAs from BSR cells, uninfected (C,
lane 2) or infected with Clone 13 (C, lane 1) were analyzed as a control. The
probes detected the CAT sense (A), antisense (B) or the NSs sequence in the
sense orientation (C).
Fig. 2. Detection and quantification of CAT activity mediated by CAT minigenomes. (A) Kinetics of CAT expression recovered from LgCAT minigenome. BSR cells
were transfected with 2 μg of pCMV-T7pol, 1 μg of pLgCAT, 0.25 μg of plasmid pTM1-L and 0.5 μg of pTM1-N. In the negative controls, one or both protein
expression plasmids were omitted. Cells were incubated at 37 °C for 6 h to 48 h post-transfection, CATactivity was assayed and revealed by thin layer chromatography.
The chromatogram is shown after exposure on a screen (STORM). MAc: monoacetylated chloramphenicol, NAc: nonacetylated chloramphenicol. (B) Comparison of
CAT expression from the L, M and S RVFV minigenomes. Experiments were carried out as described above and the percentage of monoacetylated chloramphenicol
was estimated. CAT activity from LgCAT at 72 h was considered as 100%.
173N. Gauliard et al. / Virology 351 (2006) 170–179antigenomes, like the authentic viral molecules (Elliott, 1996).
Northern blotting using a probe detecting CAT in the sense
orientation was performed to analyze the antigenome analogs
and the CAT mRNAs (Fig. 3A, lanes 3, 5, 7). As expected, no
background was observed in the absence of N and L protein
expression (Fig 3A, lanes 2, 4 and 6). In the case of L
segment-based minigenomes, when L and N were expressed,
it was not possible to distinguish antigenome-like molecule
and CAT mRNA from their migration in the agarose gel,
whereas two bands were detected in cells transcribing the M
and S minigenomes (Fig. 3A). Taking the viral context as a
reference, we assumed that the slow migrating band
corresponds to the antigenome analog, and the faster migrating
one corresponds to the CAT mRNA. For the authentic M
mRNA, the 3′ end was mapped (Collett, 1986) and located at
some 110 nt before the end of the template. The difference in
mobility between the two CAT RNAs suggests that termina-
tion occurs at the expected signal in the M analog. Using size
markers and the three segment-based CAT minigenomes, we
estimated the fast migrating RNA expressed from SC13gCAT
template to be approximately 780 nt in length. This is in
agreement with the fact that this CAT mRNA contains a 5′
capped extension of 10–18 bases, the 5′ antigenomic NCR of
S (38 nt), the CAT gene (661 nt) and most of the IGR,
suggesting that the transcriptase terminates after copying most
of the IGR, like in the case of the N mRNA in RVFV infected
cells. Additionally, since the SC13gCAT template is ambi-
sense, we checked by Northern blot analysis if the NSs mRNA
was transcribed. Fig. 3C shows that although in small
proportion, the NSs mRNA was synthesized, and it co-
migrated with the NSs mRNA from Clone 13-infected cells.
Altogether, these data showed that the termination signals for
both mRNAs are present in the IGR, and that the
minigenomes are bona fide templates for transcription and
replication.
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transcription–replication
When we compared CAT expression from the genomic L, M
and S minigenomes, we found that CAT activity was 1.7 times
stronger when expressed from pLgCAT than from pMgCATand
1.6 times stronger than from the pSC13gCAT (Fig. 2B). In other
words, the relative efficiency of the promoters was 100%, 59%
and 64% for the L, M and S RNA species, respectively. These
ratios did not change over the course of the experiment. We
verified that the truncated NSs of Clone 13 has no effect on viral
transcription by using a pSC13mgCAT (m for mutated) in
which the NSs ATG start codon was mutated into a TGA codon:
CAT activity recovered from this plasmid gave similar results
compared to the pSC13gCAT plasmid (not shown).
The relative transcription–replication activity in infected
cells seems in contrast with the results obtained from the
minigenome system: the transcription–replication activity of
the L molecules is the lowest in infected cells, whereas the L
promoter assessed by the minigenome comparison is the
strongest. This is, however, an apparent paradox since in the
minigenome analysis, the three templates are of similar size,
whereas the sizes of the authentic molecules are quite different.
Theoretically, the efficiency for RNA synthesis of the L, M and
S species must be proportional to the strength of the promoter
(100%, 59% and 64%, respectively) and inversely proportional
to the length of the L, M and S molecules, i.e., 6404 nt, 3886 nt
and 1141 nt, respectively. Thus, the size correction factor is 1
for L, 1.6 (i. e. 6404: 3886) for M and 5.6 (i. e. 6404: 1141) for S
and the theoretical molar ratio of the RNA species in infected
cells must be 1 for L, 0.97 (i. e. 0.59 × 1.6) for the M species and
3.55 (i. e. 0.64 × 5.6) for the S species. This theoretical
calculation shows that the S species takes advantage because of
its small size, but it assumes also that the three RNA species are
in equimolar ratios. Thus, the proportion of the L, M and S
species in infected cells have to be corrected, knowing that the
relative amounts of the input RNPs from the Clone 13 infecting
virus are 1 for L, 3.9 for M and 3.9 for S (see Fig 1). When this
parameter was introduced, the calculation leads to the following
theoretical molar ratio in infected cells: 1 for L, 3.8 for M and
13.8 for S. These values were close to those observed in infected
cells, which are 1:2.8:12.3. Therefore, these results strongly
suggest that the cis-acting elements present in the NCRs of each
minigenome control the level of transcription–replication in a
manner similar to the situation encountered in RVFV-infected
cells.
Discussion
In this study, we described a Pol I-driven RVFV
minigenome rescue system and showed that it is functional
for the reconstitution of virus-like RNPs fully active for
transcription and replication. The three types of transcription
products were synthesized, and the ratios between mRNA and
antigenomes (cRNAs), at least those derived from the S
segment-based minigenomes (Fig 3A, lane 7) or the S segment
in RVFV-infected cells (not shown), were similar, indicatingthat transcription–replication was regulated similarly in both
systems. The mRNAs are likely to possess 5′ capped
extension since expression of the recombinant L protein was
shown to carry out cap snatching (Lopez et al., 1995). In
addition, CAT mRNAs expressed from M and S segment-
derived minigenomes terminate at a signal located in the 5′
NCR or in the IGR, respectively. The presence of the IGR in
the S segment-based minigenome plasmid is important to
assess the level of expression since an S CAT template lacking
the IGR (SgCAT) was found to be much less active than
SC13gCAT (data not shown). Similar results were observed
with UUKV minigenome (Flick et al., 2004). Likely, the
SgCAT template lacking the transcriptase termination signal
generates CAT mRNAs containing the complete 5′ and 3′
NCRs which can form a panhandle structure and impede
efficient translation. The termination signal present in the M
segment …GGGGTGGTGGGG… (Collett, 1986) is likely
recognized by the reconstituted complex (Fig 3A, lane 5). The
question of the transcription termination site has to be
addressed for the RVFV L mRNA because such a sequence
is not present in the 3′ NCR of the L segment, and no
termination site was determined. Considering that the
transcription products from the segment-derived minigenome
migrated as a unique band, it could be that the L mRNA and
the antigenomes (cRNA) have the same size, as it occurs for
the L mRNA of Sin Nombre (Hutchinson et al., 1996).
The minigenome rescue system allowed assessing the
relative promoter efficiencies of the L, M and S minigenomes
by measuring CATactivities. The validity of assessing promoter
strength by the reporter activity of genome analogs was already
raised for Bunyamwera virus minigenome, and an excellent
correlation was found between reporter gene activity and direct
labeling of the minigenome analogs (Barr et al., 2003; Kohl et
al., 2004a). Because of the similarity of the systems, this should
be true also for the RVFV minigenomes. A possible bias could
occur if CAT expression is influenced by the context of the
initiating AUG (Kozak, 2002). In all the minigenomes, position
+4 is the same, due to the CAT ORF and position −3 depends
on the sequence of the NCR. For RVFV L and S minigenomes,
position −3 is an A and therefore is optimal, whereas for the M
minigenome, position −3 is a U, leading to a less favorable
translation efficiency. On this basis, one could consider that the
activity resulting from the M minigenome is underestimated.
However, the AUG context for CAT expression might not have
a significant effect since for Bunyamwera and Uukuniemi virus
minigenomes, essentially no difference in CAT activity was
found when the translational context was changed to be optimal
(Flick et al., 2004; Kohl et al., 2004a). Therefore, it is
reasonable to consider that evaluation of CAT activities
represent a valid method to assess the efficiency of the L, M
and S promoters.
Altogether, our results indicated that the NCRs contain the L,
M and S promoters, the strength of which is in the order
L > S > M, whereas the level of genome segment transcription
and replication in infected cells is almost in the opposite order
S > M > L. Theoretically, this can be explained merely by the
fact that the larger the molecule to transcribe and replicate, the
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carried out with the related Phlebovirus UUKV and the
orthobunyavirus Bunyamwera, the M segments were shown to
have the highest transcription–replication ability, followed by
the L and S segments (Barr et al., 2003; Flick et al., 2004; Kohl
et al., 2004a). Although it is beyond the scope of this paper to
elucidate the mechanism leading to differential RVFV promoter
activities, it is interesting to speculate on the elements present in
the NCR and possibly involved in regulation. Several factors or
elements have to be considered, among which sequence
variations and structures. Except for the extreme terminal
nucleotides conserved among segments and viruses of the same
genus, the remaining sequences of the NCRs are specific for
each segment. Fig. 4 illustrates the sequence and potential
structure of the L, M and S RVFV CATminigenome panhandles
predicted using theM-fold programme (Zucker et al., 1999). The
difference of promoter strength could be due to a particular
sequence and/or structure within the NCRs. These elements
could influence the binding of the L protein and/or its capacity to
initiate transcription as well as the ability of the nucleoprotein to
bind RNA. In influenza virus promoter, the 5′ sequence of the
panhandle determines the binding of the polymerase, whereas
the 3′ sequence influences the transcription initiation (Li et al.,
1998). Also, it appears that increased complementarity between
the 3′ and 5′ sequences influenced the efficiency of the
transcriptase. Indeed, in the case of Bunyamwera virus, it was
shown that the 3′ and 5′ NCRs do not act independently but
rather cooperate to form a functional promoter and a minimal
length of base-paired ends, up to nt 15 or 16, is required for
functionality (Barr and Wertz, 2004). To some extent, this wasFig. 4. Panhandle structures predicted for the L, M and S CAT minigenome. The
M-fold programme was used to determine the secondary structures of the full-
length L, M and SC13 CAT minigenomes. Only the terminal regions forming
panhandle between 3′ and 5′ ends are shown.shown also for UUKV minigenome (Flick et al., 2004), and it is
suggested for RVFV by the fact that chimeric CAT constructs in
which the 5′ NCR of the M segment was associated with the 3′
NCR of the L or S segment were not functional for
transcription–replication (not shown). Additionally, data re-
ported by Kohl et al. indicated that a point mutation at nucleotide
16 in Bunyamwera virus S segment introducing a loop structure
in the panhandle and a decrease in free energy was responsible
for a strong increase of N mRNA transcription (Kohl et al.,
2003). In terms of secondary structure, a loop is predicted within
the RVFV S panhandle, next to the stem formed by the terminal
8 base-paired nucleotides (Fig 4). This is a major difference with
the structure predicted for UUKV S segment which might
explain that the promoter of UUKVS segment is the weakest of
the three genomic segments (Flick et al., 2004). Mutational
analysis would help to elucidate this question by disrupting the
loop structure in the RVFV S minigenome and introducing
mutations to generate complementary sequences. Moreover, the
5′ NCRs of the L and M segments are long, and only the base
paired structures of RVFVare shown in Fig 4. Similar structures
are predicted for the L and M panhandles of UUKV, with a loop
in the L segment and a bulge in the M one (not shown).
However, the L segment promoter is stronger within the RVFV
genome, whereas this is the M one in the UUKV genome. Why
these differences exist among these two viruses is not clear.
Particular sequences and structures present downstream of the
panhandle must be important to modulate the promoter.
Mutational studies using the minigenome system will be
necessary to identify the cis-acting elements present in each
NCR affecting the strength of the RVFV promoter. One should
also keep inmind that, as described for Bunyamwera virus (Kohl
et al., 2004b), relative promoter strength might depend on the
cell type in which the minigenome is functioning and suggesting
that cellular factors might be involved.
Material and methods
Cells lines and virus strains
BSR cells were grown in Glasgow's modified Eagle's
medium (GMEM, Gibco-BRL) supplemented with 5% fetal calf
serum, 10 IU of penicillin/ml and 10 μg of streptomycin/ml.
BHK-21 cells were grown in GMEM supplemented with 5%
fetal calf serum, 5% tryptose phosphate broth, 10 mM of
HEPES, 10 IU of penicillin/ml and 10 μg of streptomycin/ml.
RVFV Clone 13 and MP12 were grown by infecting Vero E6
cells at a low multiplicity of infection (MOI) of 0.01. The
maintenance medium, Dulbecco's medium containing 2% fetal
calf serum and antibiotics was collected at 72 hpi and stored at
−80 °C.
Construction of plasmids
The sequences representing the ORFs of N and L proteins
were amplified by RT-PCR from MP12 RNA extract and
cloned into the pTM1 plasmid, yielding pTM1-N and pTM1-L.
The PCR primers used for plasmid constructions are shown in
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used for expression of RVFV segment-like molecules under the
control of the murine RNA pol I promoter (Neumann et al.,
1994; Zobel et al., 1993). The 5′ and 3′ NCR cDNAs of L, M
and S RVFV MP12 were inserted between the rRNA gene
promoter region (−251 to −1 relative to the 45 S pre-rRNATable 1
Names and sequences of the primers used for the plasmid constructionstart point) and the rDNA terminator sequence (+571 to +745
relative to the 3′ end of the 28 S rDNA), in genomic (g) or
antigenomic (ag) orientation for vRNA and cRNA transcrip-
tion, respectively. The pLgNC and the pMgNC were
constructed using the primers RVFL5NC/RVFL3NC and
RVFM5NC/RVFM3NC, respectively. The RVFL3NC and the
177N. Gauliard et al. / Virology 351 (2006) 170–179RVFM3NC primers contain the complete 3′ NCR of L or M, a
BbsI-XhoI-BbsI cloning site and the last nucleotides of the 5′
NCR of L or M. The pSgNC was constructed using the
oligonucleotide RVFSNCfull containing the whole 3′NCR of
the S segment followed by a BbsI-XhoI-BbsI cloning site and
the complete 5′ NCR. A double-stranded DNA product was
synthesized by the Klenow polymerase using the RVFSNCstart
primer and the oligonucleotide RVFSNCfull. The CAT reporter
gene was then cloned in antisense orientation between the
NCRs using the primer sets CATL5NC/CATL3N to yield the
pLgCAT plasmid or CATM5NC/CATM3NC for the pMgCAT
plasmid or CATS5NC/CATS3NC for the pSgCAT plasmid.
Plasmid pSinsgCAT containing the NCRs of the S segment
flanking a BbsI-XhoI-BbsI sequence and the CAT gene was
constructed by inserting the PCR product obtained using
CATS5NC/CATSins primers, into the pSgNC plasmid. Primer
CATSins contains BbsI-XhoI-BbsI cloning sites which allow
insertion of any sequence between the 5′ S NCR and the CAT
gene. The pSC13gCAT plasmid was constructed by inserting
the NSs gene and the 82 base long IGR of Clone13 using
CATIR3/NSsC13 primers into pSinsgCAT. The same method
was used to generate the pSC13mgCAT plasmid, with
CATIR3/NSsC13mut primers, which contains the NSs gene
with the initiating ATG mutated into TAG.
Plasmids pLagCAT, pMagACT, pSC13agCAT, pSC13mag-
CAT and pSagCAT, transcribing respectively the viral L, M and
S cRNA antigenome (ag) analogs were constructed using
RVFLCAT5NCag/RVFLCAT3NCag primers and pLgCAT tem-
plate, RVFMCAT5NCag/RVFMCAT3NCag primers and
pMgCAT template, and RVFSCAT5NCag/RVFSCAT3NCag
primers and pSC13gCAT or pSC13mgCAT or pSgCAT
templates, respectively. All the plasmids were checked by
sequencing.
DNA transfection
BSR cells were grown in 6-well plates up to 70–80% of
confluency. Before transfection, culture medium was replaced
by OptiMEM medium (Gibco), then cells were transfected by
DOTAP liposomal transfecting agent (Roche) according to
manufacturer's specifications. Cells were incubated for 6 to
72 h at 37 °C. Four hours post-transfection, OptiMEM medium
was removed and replaced by GMEM containing 5% fetal calf
serum.
CAT assay
BSR cell monolayers were washed with cold phosphate-
buffered saline (PBS), harvested by scraping into PBS and
recovered by centrifugation. The cell pellet was resuspended in
50 μl of 0.25 M Tris, pH 7.5. Cells were lysed by three cycles
of freezing and thawing. Cell lysate was clarified by
centrifugation (9000 × g, 4 °C). For the enzymatic assay, 7 μl
of cell extract was mixed with 86 μl of 0.3 M Tris pH 7.5, 16 μl
of 4 mM acetyl coenzyme A (Roche) and 2 μl of [14C]
chloramphenicol (10 nCi, 50–62 mCi/mmol, Amersham) and
incubated for 40 min. For quantification of CAT activities, theincubation times and the amount of lysates were adjusted so
that the reaction did not produce di-acetylated chloramphenicol
but only the monoacetylated form, indicating that the synthesis
was carried out in a linear range. The reaction products were
separated by thin-layer chromatography (TLC plate, 20 ×
20 cm; Silica Gel 60, Merck) developed with 19:1 chloroform:
methanol. Mono- and nonacetylated [14C]chloramphenicol
were visualized by autoradiography using STORM 820
(Molecular Dynamics), and CAT activity was quantified as
the proportion of monoacetylated chloramphenicol using
ImageQuant (Molecular Dynamics).
Analysis of RNA
Purification and analysis of 32P-labeled virion RNAs
Four 10-millimeter dishes of BHK-21 were infected with
Clone 13 RVFV at an MOI of 1. [32P]phosphoric acid (20 μCi/
ml) (MP Biomedicals Inc.) was added to the medium 2 h later,
and cells were harvested at 18 hpi. After clarification by
centrifugation at 3000 × g, the maintenance medium containing
32P-labeled Clone 13 virus was precipitated by PEG 6000 (7 g/
100ml) in the presence of NaCl (2.3 g/100ml) for 4 h at 4 °C and
centrifuged at 10,000 × g for 40 min. The pelleted virus was
resuspended in STE (20 mM Tris–HCl pH 7.4, 100 mM NaCl
and 1 mM EDTA) and RNA extracted with Trizol reagent LS
(Invitrogen), according to manufacturer's recommendations.
After denaturation for 1 h at 50 °C in a buffer containing 1 M
glyoxal (Merck), 50% (vol/vol) DMSO and 10 mM of MOPS
buffer, the RNAs were electrophoresed in a 1.4% agarose gel
(McMaster and Carmichael, 1977). Electrophoresis was per-
formed at 50 V in MOPS buffer (20 mM 3-[N-Morpholino]-
propane-sulfonic acid, 5 mM Na acetate, 1 mM EDTA pH 7.0).
The gel was dried at 60 °C and exposed on an X-ray film at
−80 °C.
Analysis of 32P-labeled cytoplasmic viral RNAs
Thirty minutes before infection, 10-mm dishes of confluent
BHK21 cells were incubated with actinomycin D (2 μg/ml).
Cells were infected with Clone 13 RVFV strain at an MOI of 1
or mock infected. [32P]phosphoric acid (20 μCi/ml) was then
added to the medium 30 min after infection until 7.5 h post-
infection. At that time, total cellular RNA was extracted by
Trizol reagent (Invitrogen) and analyzed as described above for
viral RNAs.
Northern blot analysis
Total cellular RNAs were extracted 24 h post-transfection by
Trizol reagent. Four micrograms of total RNAwas separated in
1.4% agarose after denaturation with glyoxal and transferred
onto Hybond-N membranes (Amersham Pharmacia Biotec).
Blots were prehybridized for 2 h at 65 °C in a solution
containing 50% formamide, 5× SSPE (1× SSPE: 0.18 M NaCl,
10 mM NaH2PO4 and 1 mM EDTA) (pH 7.0), 5× Denhardt
solution, 0.5% SDS, 2 μg per ml of boiled salmon sperm DNA.
32P-labeled riboprobes were then added to the hybridization
tube and incubated for 18 h at 65 °C. Membranes were washed
successively with 2× SSPE, 0.1% SDS twice for 10 min each at
178 N. Gauliard et al. / Virology 351 (2006) 170–179room temperature followed by 1× SSPE, 0.1% SDS at 65 °C
and by 0.1× SSPE, 0.1% SDS at 65 °C for 10 min. Membranes
were exposed to intensifying screen and revealed with STORM
820 apparatus (Molecular Dynamics).
CAT riboprobes were synthesized by in vitro transcription of
pT7CATAK, a pGEM-based plasmid containing the CAT ORF
already described (Kohl et al., 1999a), using SP6 or T7
polymerase and [α−32P]CTP (3000 Ci/mmol, Amersham).
This plasmid contains the CAT ORF between the SP6 and T7
promoters into pGEM-4Z vector at the HindIII site of the
polylinker.
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